Vontobel Holding
BCYC

Vontobel Holding’s Bicycle Therapeutics BCYC Stock Holding History

Vontobel Holding’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$92.8K Buy
20,000
+10,000
+100% +$57.1K ﹤0.01% 1153
2025
Q4 		$70.8K Buy
+10,000
New +$73.7K ﹤0.01% 1385

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vontobel Holding's BCYC Position: Q1 2026 in Review

Vontobel Holding increased its Bicycle Therapeutics (BCYC) stake by 100% in Q1 2026, buying an estimated $57.1K and bringing the position to 20,000 shares worth $92.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1153.

Vontobel Holding first reported a position in BCYC in Q4 2025 and has held it in 2 quarters since. 98 funds tracked by Wall St. Rank hold BCYC as of Q1 2026.

  • Vontobel Holding held 20,000 shares of Bicycle Therapeutics worth $92.8K as of Q1 2026.
  • Vontobel Holding bought 10,000 Bicycle Therapeutics shares in Q1 2026, an estimated $57.1K.
  • Bicycle Therapeutics made up ﹤0.01% of Vontobel Holding's portfolio in Q1 2026, its #1153 holding.
  • Vontobel Holding first reported a position in Bicycle Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 98 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2026.

Based on Vontobel Holding's 13F filing for Q1 2026, filed 8 May 2026.